Ledger.Open graph →
SEC Form D · filed July 17, 2024

NeuroLambda Therapeutics, Inc

Offering
$5.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Byungchan Kim · Cambridge, MADirectorXiaowei Jin · Little Neck, NYDirectorSayan Mondal · Cambridge, MAExec · DirectorByungchan Kim · Cambridge, MADirectorXiaowei Jin · Boston, MADirectorSayan Mondal · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗